Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C9H9NO4 |
| Molecular Weight | 195.1721 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC1=CC(=O)C(=O)C=C1)C(O)=O
InChI
InChIKey=AHMIDUVKSGCHAU-LURJTMIESA-N
InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Generalized melanosis in metastatic malignant melanoma: the possible role of DOPAquinone metabolites. | 1998 |
|
| Biochemical observations in UV-induced pigmentation. | 1988-02 |
|
| [Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration]. | 1980-07 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Dopaquinone
Created by
admin on Mon Mar 31 19:58:16 GMT 2025 , Edited by admin on Mon Mar 31 19:58:16 GMT 2025
|
PRIMARY | |||
|
16852
Created by
admin on Mon Mar 31 19:58:16 GMT 2025 , Edited by admin on Mon Mar 31 19:58:16 GMT 2025
|
PRIMARY | |||
|
25520-73-4
Created by
admin on Mon Mar 31 19:58:16 GMT 2025 , Edited by admin on Mon Mar 31 19:58:16 GMT 2025
|
PRIMARY | |||
|
439316
Created by
admin on Mon Mar 31 19:58:16 GMT 2025 , Edited by admin on Mon Mar 31 19:58:16 GMT 2025
|
PRIMARY | |||
|
8F09Y50AX6
Created by
admin on Mon Mar 31 19:58:16 GMT 2025 , Edited by admin on Mon Mar 31 19:58:16 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
